Dopamine D2/D3 receptor antagonist
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Dopamine D2/D3 receptor antagonist, covering 2014-09-15 to 2014-09-15. Get the full timeline:
Most recent: Clinical Trial Update: Characterize The Modulatory Effects Of Dopamine D2/D3 Receptor Agonist And Antagonist Drugs On Compulsive Behaviors [Phase 1]